England is soon going to start seven-minute treatment for cancer patients. Yes, you read it right. Britain's government-run National Health Service (NHS) will be the first agency in the world to offer a cancer-treating injection to hundreds of patients in England. This can reduce the time taken for treatment by up to three-fourths.

It has been approved by the British Medicines and Healthcare Products Regulatory Agency (MHRA). Following the approval, NHS England said on Tuesday that hundreds of patients being treated with the immunotherapy, atezolizumab, would be given the injection under the skin. This will provide better results and reduce time in cancer treatment.

Dr Alexander Martin, consultant and oncologist at West Suffolk NHS Foundation Trust, said: “This approval will not only help us care for our patients, but will also enable our teams to treat more patients throughout the day.

England's National Health Service reported that atezolizumab, also known as Tecentric. Tecentric is a monoclonal antibody that affects the way the immune system functions in cancer patients. It is usually given to patients through a drip directly into their veins. Trouble comes when it becomes difficult to identify the veins. In such a situation, it takes about 30 minutes or up to an hour for the patients to be put on drip.

Marius Scholtz, medical director of Roche Products Ltd., says that with the direct intravenous method, it now takes about 7 minutes, compared to 30 to 60 minutes earlier. Let us tell you, Atezolizumab Roche (ROG.S) is made by the company Genentech. It is an immunotherapy drug, which makes the patient's own immune system stronger and capable of finding and destroying cancer cells. It is currently treating NHS patients with a variety of cancers including lung, breast and liver.